Psychosocial Factors and Overall Survival After Autologous and Allogeneic BMT  by Hahn, T. et al.
Poster Session-I 55. (Continued )Patient
age/sex HCT type DiagnosisOrgan &
IndicationTime b/w
HCT & SOTFollow-up
after SOT16 F Allo MUD CML Lung,
Bronchiolitis
obliterans1.2 yrs 1 mo, dead
(multi-organ
failure)17 M Allo MUD ALL Kidney, ESRD 6.2 yrs Lost to
followupAllo sib – matched sibling donor; MUD – matched unrelated donor; CML – chronic
myeloid leukemia; AML – acute myeloid leukemia; ALL – acute lymphoblastic leukemia;
ESRD – end stage renal disease; HCV – hepatitis C144
A STUDY ON THE SEXUAL DYSFUNCTION OF FEMALE RECIPIENTS WHO
UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kim, J.W., Kim, K.S., Bok, J.N., Lee, S.Y. The Catholic University of
Korea, Seoul, Korea
Background/ Aims: Many studies have shown sexual dysfunction
in recipients who underwent HSCT, particularly for female recipi-
ents. However, there were no studies for sexual dysfunction of female
recipients who underwent HSCT in Korea, because the sexual prob-
lem was just considered very private. The purposes of this study was
to analysis the level of sexual dysfunction of female recipients who
underwent HSCT and provide basic data contributed in taking
care of female recipients having sexual problems after HSCT.
Methods: The sexual function of 60 female recipients who have
been visiting hospital after HSCT, were selected from database of
Catholic HSCT center, St. Mary’s Hospital; was assessed using the
Korean translated version of FSFI (female sexual function index)
questionnaire.
Results: More than 80% of female recipients had hematological
malignancies; more than 76.7 % were allograft recipients. Gonadal
disturbances were present in 51.7 % of female recipients. 22.5 %
of them were receiving estrogen replacement and only 23.3% had
regular menses. 61.7 % of them had never done sexual activity in
the past four weeks from the assessment date. The reason why they
didn’t have sexual activity was associate with the uninteresting of
themselves (48.3%), the fear of infection (44.9%) and the uninterest-
ing of their sexual partner (13.8%). More than 94% of female recip-
ients were found to have low level of FSFI total score as sexual
dysfunction. They were found to have each domain scores on sexual
desire, arousal, lubrication, orgasm and satisfaction as sexual dys-
function; 80.8%, 98.1%, 92.3%, 86.5%, 84.6% and 86.5%
of them respectively. These results showed significant sexual
dysfunction of female recipients who underwent HSCT.
Conclusion: The Sexual dysfunction of female recipients, who
underwent Hematopoietic Stem Cell Transplantation, is usual after
HSCT. We suggest stressing the importance of intervention for fe-
male recipients having sexual problems and there are needed to apply
hormonal, mechanical, and behavioral methods to prevent sexual
dysfunction in further studies.145
SUICIDE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTA-
TION (HSCT) PATIENTS, IS IT A PROBLEM?
Larsen, H.B.1, Petersen, H.1, Roepstorff, C.1, Sengelow, H.1,
Heilmann, C.2 1Rigshospitalet, Copenhagen, Denmark; 2Rigshospitalet,
Copenhagen, Denmark
Introduction: A review of the literature showed that the prob-
lem of suicide and suicide attempts among HSCT patients has
only been examined in two studies from the 1990´ties.
Since suicide continues to be a problem in HSCT patients we
wanted to examine the problem in a Danish population based
context.
Patients andmethods:Follow-up data from the Danish cohort of
HSCT patients (N: 1217 September 1. 2008) revealed that three pa-
tients had committed suicide, and that at least three patients had
attempted to do so.Results: The three patients who committed suicide were all
males, two of them were severely ill, one with a prolonged inpatient
period due to transplantation complications and one had recently
been diagnosed with relapse following HSCT. The last patient
was 10 years from HSCT and suffered from depression. Whether,
in the Danish cohort, other patients have committed suicide may be
a matter of definition e.g. a patient, who refused to take his medi-
cine, because he did not wish to live, die three months later due
to GvHD. The three patients whom we know attempted suicide
are all females, and their attempts occurred approximately 10 years
after HSCT, during childhood or adolescence. One patient has se-
vere extensive long-term complications following HSCT and the
other two patients have been complaining of depressive thoughts.
Whether other patients have attempted suicide is unknown, but it
is likely that our follow-up data collection does not always pick
up such events.
Conclusion: Suicide and suicide attempts are not well described
in the HSCT literature. It’s unknown whether we actually capture
all suicides and suicide attempts in our medical records and by our
data collection procedures. It’s also unknown what the incidence
of suicide is following treatment with HSCT. We would therefore
suggest a multicenter/registry analysis of the problem. In order to
capture information regarding HSCT patients that commit suicide
we need to know their age, gender, time after HSCT, complications
(e.g. GvH, infection) and psychological profile. This would provide
us with further knowledge and understanding of the problem, and
hopefully help us care better for patients at risk for post transplanta-
tion suicide.146
PANCREATIC ATROPHY IS ASSOCIATED WITH GASTROINTESTINAL
CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Nakasone, H.1,2, Ito, A.1, Endo, H.1, Muramatsu-Kida, M.1, Izutsu, K.1,
Usuki, K.1 1Kanto Medical Center, NTT, EC; 2Saitama Medical Center,
Jichi Medical University Graduate School
The weight loss and malnutrition commonly observed in patients
following hematopoietic stem cell transplantation is due to pancre-
atic insufficiency, at least in part. To date, few reports have evaluated
pancreatic morphology in the chronic phase of transplantation. We
evaluated pancreatic atrophy following allogeneic peripheral blood
stem cell transplantation (PBSCT) by retrospectively reviewing pa-
tients with chronic graft-versus-host disease (cGVHD) following
PBSCT from related donors. The study was carried out at our insti-
tution between June 2001 and October 2007. Computed tomogra-
phy (CT) scans were available for pre- and post-transplantation
pancreatic assessment from 25 of 26 patients with cGVHD who
had survived at least 100 days. The median patient age was 60 years.
Sixteen patients received fludarabine-based reduced-intensity condi-
tioning regimens. The median duration of observation for survivors
was 4.1 years. Pancreatic atrophy was observed in five (20%) of 25
patients, while steatorrhea was documented in only one (5%). Uni-
variable analysis revealed that pancreatic atrophy was significantly
associated with involvement of liver (P5 0.041) and gastrointestinal
(GI) tract (P 5 0.022) of cGVHD, while multivariable analysis
showed that only GI cGVHD was a significantly associated factor
[OR: 16.0 (95%CI: 1.1–364), P 5 0.043]. Overall survival (OS) be-
tween patients with and without pancreatic atrophy was similar
(40.0% and 56.3%, respectively; P 5 0.98). Morphological assess-
ment by CT detected pancreatic abnormalities more sensitively, eas-
ily, and less invasively than assessment via steatorrhea observation or
biopsy. Pancreatic atrophy is not a rare complication of PBSCT in
patients with cGVHD, particularly in those with GI cGVHD.147
PSYCHOSOCIAL FACTORS AND OVERALL SURVIVAL AFTER AUTOLOGOUS
AND ALLOGENEIC BMT
Hahn, T.1, Jensen, S.1, Lopez, F.1, Zevon, M.1, Tan, W.2, Wilding, G.2,
Paddon, C.1, White, J.1, Thomas, J.1, Battiwalla, M.1, Smiley, S.L.1,
McCarthy, P.L.1 1Roswell Park Cancer Institute, Buffalo, NY; 2Roswell
Park Cancer Institute, Buffalo, NY
Various psychosocial factors have been assessed in BMT patients
(pts), but there are few reports of a comprehensive psychosocial
56 Poster Session-Ievaluation pre-BMT predicting outcomes post-BMT. We retrospec-
tively analyzed 204 consecutive first adult ($18 years) autologous (n
5 108) or allogeneic (n 5 96) BMT pts treated from 7/05 to 5/08 to
analyze BMT outcomes in relation to a comprehensive psychosocial
evaluation. 200/204 (98%) had a psychosocial inventory assessment
collected by in-person interview with a BMT social worker during
their routine pre-BMT evaluation. The psychosocial inventory had
questions regarding employment, marital status, education, financial
concerns, transportation and local lodging needs, degree of under-
standing of diagnosis and treatment, tobacco, alcohol and drug use, im-
portance of and comfort with religious beliefs, and personal or family
suicidal ideation or attempt. Median age was 53 years (range 18–74),
62% were male, 93% were White, diagnoses included leukemia (n5
73), lymphoma (n 5 71), myeloma (n 5 36), hematologic disorders
(n 5 17), and solid tumors (n 5 3), donors were autologous (n 5
106), related (n 5 41), or unrelated (n 5 53). Median follow-up in
the survivors was 1.1 years (range 0.1–3). By univariate analysis, signif-
icant predictors of decreased 1-year overall survival (OS) in allogeneic
BMT pts were KPS # 80 (47% vs. 75%, p 5 0.003), marital status
(married 39% vs. never married 69% vs divorced 90%, p 5 0.016),
not living alone pre-BMT (48% vs. 100%, p5 0.012) and smoking sta-
tus (ever 42% vs. never 67%, p5 0.07). Marital status was significantly
related to age with median 53 vs. 36.5 vs. 46.7 years of married vs. never
married vs. divorced pts. By univariate analysis, the only significant
predictor of decreased 1-year OS in autologous BMT pts was living
.30 minute drive from the BMT center and needed local lodging
(72% vs. 93%, p5 0.006). For allogeneic BMT, multivariate analysis
demonstrated KPS#80 (RR54.6, 95% CI 1.4–15, p50.01), married
compared to divorced (RR5 5.9, 95% CI 0.8–44, p5 0.08) and for-
mer/current smokers (RR5 1.8, 95% CI 0.9–3.4, p5 0.08) had an in-
creased risk of death. Substituting age for marital status in the model
yielded only KPS as a significant factor. Some psychosocial factors
may be related to patient and disease related characteristics which
may yield selection bias in the decision to transplant or not. Further
analyses of psychosocial factors in larger, more homogeneous patient
populations may help clarify risk subgroups.148
INCIDENCE, CHARACTERISTICS AND OUTCOME OF CYTOMEGALOVIRUS,
ADENOVIRUS, AND BK VIRUS CO-INFECTION IN PEDIATRIC RECIPIENTS
OF STEM CELL TRANSPLANT
Watcharananan, S.1, Kiertburanakul, S.1, Premchaiporn, K.2,
Anurathapan, U.3, Sungkanuparph, S.1, Chantratita, W.2,
Pakakasama, S.3, Hongeng, S.3 1Faculty of Medicine, Ramathibodi Hospi-
tal, Mahidol University, Bangkok, Thailand; 2Bangkok, Thailand;
3Bangkok, Thailand
Introduction: Viral infections are a common cause of complica-
tion after hemopoietic stem cell transplantation (HSCT). Data on vi-
ral co-infection following HSCT in pediatrics is limited. We studied
the incidence, clinical characteristics and outcome of cytomegalovi-
rus (CMV), adenovirus (ADV), BK virus (BKV) and JC virus (JCV)
co-infection in pediatric recipients of HSCT.
Methods: We performed quantitative PCR of ADV, BKV and
JCV in 191 blood samples from 73 pediatric patients, initially tested
for quantitative CMV PCR following HSCT. We retrospectively re-
viewed medical records among these patients.
Results: Viral DNA was presence in 55 (75.3%) of 73 patients.
The incidence of viral detection was highest for BKV, followed by
CMV, ADV and JCV (24, 16, 8 and 0.4 cases per 1000 person-weeks,
respectively). The median plasma CMV, ADV and BKV viral load
(copies/ml) was 8,350, 8,380 and 77.2, respectively. Viral co-
infection was common and occurred in 27 (37%) of 73 patients, of
whom 22 and 5 were dual and triple viruses, respectively. The major
viral co-infections were CMV plus BKV, ADV plus BKV, and CMV,
ADV plus BKV ((12 (16.4%), 6(8.2%) and 5(6.8%) of 73 patients, re-
spectively). A peak ADV viral load was significantly higher in patients
who had ADV viral co-infection as compared to ADV mono-
infection (p 5 0.017), whereas a peak CMV viral load did not differ
between patients with CMV viral co-infection and CMV mono-
infection (p 5 0.218). In contrast, a peak BKV viral load was signif-
icantly higher in patients who had BKV mono viral infection than
BKV viral co-infection (p 5 0.003). From multivariate analysis,
type of HSCT was significantly associated with viral co-infection(OR 4.2 (95%CI 1.6–10.7, p 5 0.003) and allogeneic HSCT from
unrelated donor was the most predominant. Symptomatic infection
occurred in 25 patients, of whom 15 (55.6%) had viral co-infection.
Hemorrhagic cystitis was noted to be the only presentation in 15
(60%) whereas multi-organ dysfunction was noted in 7 (28%) of
25 patients. Among patients with multi-organ dysfunction, peak viral
load of CMV, ADV and BKV was higher, more types of virus
co-reactivation were detected and 5 of them had died.
Conclusion: In pediatric HSCT, symptomatic viral co-infection
is common.Patients who succumbed with the more types of virus
co-reactivation had higher probability of having multiple-organ dys-
functions. Routine ADV and BKV PCR monitoring is encouraged in
pediatric recipients of allogeneic HSCT.149
RELATED DONOR OUTCOMES FROM THE JAPANESE REGISTRY – THE
IMPORTANCE OF PRE-REGISTRATION SYSTEM
Kodera, Y.1,2,3, Miyamura, K.2,3, Nagafuji, K.2,3, Hino, M.2,3, Kim, S.2,3,
Suzuki, R.2,3 1Aichi Medical University, Nagakute-cho, Aichi, Japan;
2Nagoya University, Nagoya, Japan; 3Nagoya University, Nagoya, Japan
Background:Although peripheral blood stem cell (PBSC) donation
has been considered safe and less stressful, certain fetal or life-threaten-
ing accidents have been reported among donors. Since the Japan Mar-
row Donor Program requires the confirmation of the safety and the
risk of PBSC donation at family donorsprior toapplying this technique
for volunteer donors, the Japan Society for Hematopoietic Cell Trans-
plantation (JSHCT) has established a nation-wide consecutive pre-
registration system for PBSC family donors.
Methods: The JSHCT mandates the registration of every PBSC
family donor at the donor registration center then, issues donor iden-
tification number toeachdonor. The society alsorequires every harvest
center to observe the JSHCT standards for donor eligibility and to no-
tify it of any severe adverse events, the results of a day30 check and of
the annual health check for five years. The cost for the day 30 check
is covered by the national health insurance in Japan and the cost of
the annual health check for 5 years is covered by the JSHCT with
the support of two G-CSF producing and (or) marketing companies.
To gather information on bone marrow family donors, the JSHCT
collaborated with the European Blood and Marrow Transplant Group.
Findings: Our prospective survey revealed that certain acute se-
vere adverse events occurred even in donors who had been confirmed
to be healthy. However, no mortality nor morbidity cases were
found, suggesting that the pre-registration system with its standards
for donor eligibility has been effective in preventing real life-threat-
ening adverse events. The results of the annual health check for 5
years showed that the incidence of hematological malignancies
among PBSC donors was not high compared with that among retro-
spectively surveyed bone marrow donors.
Interpretation: The donor pre-registration system that sets strict
standards for donor eligibility is useful to know the real figures on
PBSC donors and to assure donor safety. Such a system should be
applied to all hematopoietic stem cell donors.LEUKEMIA
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MONOCULTURE-DERIVED LEUKEMIA AND MULTIVIRUS SPECIFIC CYTO-
TOXIC T-LYMPHOCYTES FOR IMMUNOTHERAPY OF ALL IN HEMATOPOI-
ETIC STEM CELL AND UMBILICAL CORD BLOOD TRANSPLANTS
Micklethwaite, K.P.1, Savoldo, B.1, Cooper, L.J.2, Schpall, E.J.2,
Rooney, C.M.1, Heslop, H.E.1, Brenner, M.K.1, Bollard, C.M.1,
Dotti, G.1 1Baylor College of Medicine, Houston, TX; 2MD Anderson
Cancer Center, Houston, TX
Infusion of donor derived cytomegalovirus (CMV), adenovirus (Ad)
and Epstein-Barr-Virus (EBV) specific cytotoxic T lymphocytes
(CTLs) appears to safely protect against viral infections post hemato-
poietic stem cell transplantation (HSCT). HSCT for pre-B acute lym-
phoblastic leukemia (B-ALL) is associated with a high rate of relapse.
We hypothesized that monoculture-derived multivirus specific CTLs
can be engineered to express chimeric antigen receptors (CAR) specific
